...
首页> 外文期刊>Journal of applied physiology >Pulse transit time measured from the ECG: an unreliable marker of beat-to-beat blood pressure.
【24h】

Pulse transit time measured from the ECG: an unreliable marker of beat-to-beat blood pressure.

机译:从心电图测得的脉搏传播时间:心跳搏动血压的不可靠指标。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The arterial pulse-wave transit time can be measured between the ECG R-wave and the finger pulse (rPTT), and has been shown previously to have a linear correlation with blood pressure (BP). We hypothesized that the relationship between rPTT, preejection period (PEP; the R-wave/mechanical cardiac delay), and BP would vary with different vasoactive drugs. Twelve healthy men (mean age 22 yr) were studied. Beat-to-beat measurements were made of rPTT (using ECG and photoplethysmograph finger probe), intra-arterial radial pressure, PEP (using cardiac bioimpedance), and transit time minus PEP (pPTT). Four drugs (glyceryl trinitrate, angiotensin II, norepinephrine, salbutamol) were administered intravenously over 15 min, with stepped dosage increase every 5 min and a 25-min saline washout between agents. All subjects in all conditions had a negative linear correlation (R2 = 0.39) between rPTT and systolic BP (SBP), generally constant between different drugs, apart from four subjects who had a positive rPTT/SBPcorrelation with salbutamol. The 95% limits of agreement between measured and rPTT-predicted SBP were +/-17.0 mmHg. Beat-to-beat variability of rPTT showed better coherence with SBP variability than it did with heart rate variability (P < 0.001). PEP accounted for a substantial and variable proportion of rPTT (12-35%). Diastolic (DBP) and mean arterial BP (MAP) correlated poorly with rPTT (R2 = 0.02 and 0.08, respectively) but better with pPTT (rPTT corrected for PEP, R2 = 0.41 and 0.45, respectively). The 95% limits of agreement between measured and pPTT-predicted DBP were +/- 17.3 mmHg. In conclusion, the negative correlation between rPTT and SBP is generally constant, even with marked hemodynamic perturbations. However, the relationship is not reliable enough for rPTT to be used as a surrogate marker of SBP, although it may be useful in assessing BP variability. DBP and MAP cannot be predicted from rPTT without correction for PEP. The significant contribution of PEP to rPTT means that rPTT should not be used as a marker of purely vascular function.
机译:可以在ECG R波和手指脉搏(rPTT)之间测量动脉脉搏波的传播时间,并且先前已证明它与血压(BP)呈线性相关。我们假设,rPTT,射血前期(PEP; R波/机械性心脏延迟)和BP之间的关系会随血管活性药物的不同而变化。研究了十二名健康男性(平均年龄22岁)。逐搏测量是通过rPTT(使用ECG和光体积描记器手指探针),动脉内径向压力,PEP(使用心脏生物阻抗)和减去PEP的渡越时间(pPTT)进行的。四种药物(三硝酸甘油酯,血管紧张素II,去甲肾上腺素,沙丁胺醇)在15分钟内静脉内给药,每5分钟逐步增加剂量,药物之间的盐水冲洗时间为25分钟。在所有情况下,所有受试者在rPTT和收缩压(SBP)之间均呈负线性相关(R2 = 0.39),在不同药物之间通常保持恒定,除了四名受试者与沙丁胺醇的rPTT / SBP相关性均为正。测量和rPTT预测的SBP之间的一致性的95%限制为+/- 17.0 mmHg。 rPTT的逐搏变异性与SBP变异性相比,其心率变异性表现出更好的一致性(P <0.001)。 PEP占rPTT的较大且可变的比例(12-35%)。舒张压(DBP)和平均动脉血压(MAP)与rPTT的相关性较差(分别为R2 = 0.02和0.08),而与pPTT的相关性更好(与pPTT校正的rPTT,分别为R2 = 0.41和0.45)。 pPTT预测值与pPTT预测值之间的一致性的95%限制为+/- 17.3 mmHg。总之,即使有明显的血液动力学扰动,rPTT和SBP之间的负相关性也通常是恒定的。然而,尽管该关系对于评估BP变异性可能有用,但对于将rPTT用作SBP的替代标记而言,其可靠性还不够可靠。如果不对PEP进行校正,则无法根据rPTT预测DBP和MAP。 PEP对rPTT的重要贡献意味着rPTT不应用作单纯血管功能的标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号